CEO
Innovative biotech founder and executive, leading Apex Bio in the mission to advance brain health through pioneering products and cutting-edge research addressing neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS. With a strong background in technology-driven product strategy and a passion for transforming operational experience into real-world impact, I guide multidisciplinary teams in developing solutions at the intersection of molecular science, data, and patient outcomes.
Rom expertise spans:
Early-stage biotech venture leadership and commercialization
Product development for neurodegenerative therapeutics and diagnostics
Building and scaling high-performing scientific teams
Grant applications and non-dilutive funding strategy
Effective scientific communication, multimedia, and video content design for industry and public engagement
Portfolio management and charge transparency analysis in health finance
Driven by a vision to maximize patient outcomes and societal benefit, Rom foster collaborations across industry and academia, championing a culture of innovation and integrity. Skilled in synthesizing complex medical and economic data, I focus on delivering actionable insights and sustainable value for stakeholders, partners, and end users.